Iterative Health uses artificial intelligence-based precision medicine in Gastroenterology (GI), with the aim of helping to optimize clinical trials investigating the treatment of Inflammatory Bowel Disease (IBD). It offers advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians better assess patients with potential GI problems. The company was formerly known as Iterative Scopes, Inc and changed its name to Iterative Health, Inc.